Home › Obesity › Texas › Grand Prairie
Obesity clinical trials in Grand Prairie, TX
13 studies for Obesity are looking for participants at sites in and around Grand Prairie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- Epic Medical Research, DeSoto · 14 mi away
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, DeSoto · 14 mi away
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RecruitingPhase 3
- Epic Medical Research - DeSoto, DeSoto · 14 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
RecruitingPhase 3
- AURORA-1 Clinical Site, DeSoto · 14 mi away
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
RecruitingPhase 3
- AURORA-2 Clinical Site, DeSoto · 14 mi away
- AURORA-2 Clinical Site, Waxahachie · 26 mi away
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Dallas Heart and Vascular Consultants, Duncanville · 8 mi away
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RecruitingPhase 3
- Epic Medical Research, DeSoto · 14 mi away
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
RecruitingPhase 3
- Epic Medical Research, DeSoto · 14 mi away
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
RecruitingPhase 3
- Kailera Clinical Site, DeSoto · 14 mi away
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
RecruitingPhase 3
- Epic Medical Research - Red Oak, DeSoto · 14 mi away
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
RecruitingPhase 3
- Kailera Clinical Site, DeSoto · 14 mi away
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Epic Medical Research - DeSoto, DeSoto · 14 mi away
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Dallas Heart and Vascular, Duncanville · 8 mi away
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
Other studies in Grand Prairie
- Overweight11 studies
- Major Depressive Disorder11 studies
- Depression8 studies
- Schizophrenia8 studies
- Steatotic Liver Disease5 studies
- Heart Failure4 studies
- COPD3 studies
- Mood Disorders3 studies
- Type 2 Diabetes3 studies
- Psychotic Disorders3 studies
- Migraine3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.